Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PLAB | Common Stock | Options Exercise | $85.8K | +9.69K | +6.07% | $8.86 | 169K | Jan 18, 2022 | Direct | |
transaction | PLAB | Common Stock | Sale | -$190K | -9.69K | -5.72% | $19.57 | 160K | Jan 18, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PLAB | Stock Options (Right to Buy) | Options Exercise | $0 | -9.69K | -100% | $0.00* | 0 | Jan 18, 2022 | Common Stock | 9.69K | $8.86 | Direct |
Id | Content |
---|---|
F1 | The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Progler. |
F2 | Net proceeds of sale to fund children's education. |